Back Page - Pharmaceutical Executive

ADVERTISEMENT

Back Page
A pharma miscellany.

Sickle Cell Disease In Three Acts

April 22, 2014

Ben Comer reports on how new pipeline therapies, public research investments, and a renewed sociopolitical focus are working toward a happier outcome for sickle cell disease patients.

Biosimilars or Bust

January 21, 2014

Where are the biosimilars to help cut costs as the first wave of biologics, or complex, small molecule respiratory drugs, for example, go off patent? They've arrived in Europe, but the U.S. lags...

Brand vs. Generic: Physicians Weigh In

December 1, 2013

Why do some doctors prescribe more generic drugs than others?

Top Medical Innovations for 2014

November 1, 2013

At the conclusion of the Cleveland Clinic's Medical Innovations Summit each year, 10 innovative technologies are unveiled before the audience, and designated as new and revolutionary tools for the treatment of disease and disability.

Using Data to Influence Behavior and Predict Outcomes

October 1, 2013

Predictive analysis has been used to great effect in the finance, tech, retail, and telecoms industries. Can it also improve decision-making and health outcomes in life sciences?

Share of Screen: Prioritizing Electronic Health Records

September 1, 2013

Are electronic health records a viable channel for engagement? Ben Comer reports.

Take a Chill Pill

August 1, 2013

In the spirit of lawn chair cogitation and hammock-spun reverie, Pharm Exec invites you to submit your own verses—pharma-related, of course—to be published on our website in late August.

What is a Journal Reprint Worth?

July 1, 2013

Pharma and physicians worry about getting sunburned by the Sunshine Act.

From Locked Box to Data Sphere

June 1, 2013

Project Data Sphere aims to liberate clinical trial data sets from industry and academic vaults, in an attempt to catalyze cancer research and discovery.

ADVERTISEMENT

Click here